Multiplex Newborn Screening for Pompe, Fabry, Hunter, Gaucher, and Hurler Diseases Using a Digital Microfluidic Platform

PURPOSE: New therapies for lysosomal storage diseases (LSDs) have generated interest in screening newborns for these conditions. We present performance validation data on a digital microfluidic platform that performs multiplex enzymatic assays for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sista, Ramakrishna S., Wang, Tong, Wu, Ning, Graham, Carrie, Eckhardt, Allen, Winger, Theodore, Srinivasan, Vijay, Bali, Deeksha, Millington, David S., Pamula, Vamsee K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3926752/
https://ncbi.nlm.nih.gov/pubmed/23660237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cca.2013.05.001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller